Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nusantara Sejahtera Raya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp93 (market cap 7.75T), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 576.7B). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 13.4× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| CNMA | LABS | |
|---|---|---|
Market Cap | 7.75T | 576.7B |
Indicative Equilibrium Price | 94 | 146 |
Indicative Equilibrium Volume | 1.17K | 11 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nusantara Sejahtera Raya Tbk.
PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.
Read more on CNMA →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
